Pretreatment Lymphocyte to Monocyte Ratio is an Independent Prognostic Factor in Metastatic Clear Cell Renal Cell Carcinoma

Ljungberg, 2010, EAU guidelines on renal cell carcinoma: the 2010 update, Eur Urol, 58, 398, 10.1016/j.eururo.2010.06.032 Heng, 2013, External validation and comparison with other models of the International Metastatic Renal-Cell Carcinoma Database Consortium prognostic model: a population-based study, Lancet Oncol, 14, 141, 10.1016/S1470-2045(12)70559-4 Motzer, 2004, Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma, J Clin Oncol, 22, 454, 10.1200/JCO.2004.06.132 Roxburgh, 2010, Role of systemic inflammatory response in predicting survival in patients with primary operable cancer, Future Oncol, 6, 149, 10.2217/fon.09.136 Gu, 2015, The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis, PLoS One, 10, e0125538, 10.1371/journal.pone.0125538 Saroha, 2013, Lymphopenia is an independent predictor of inferior outcome in clear cell renal carcinoma, J Urol, 189, 454 Huang, 2015, Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status, Cancer, 121, 545, 10.1002/cncr.29100 Gu, 2016, Prognostic role of lymphocyte to monocyte ratio for patients with cancer: evidence from a systematic review and meta-analysis, Oncotarget, 7, 31926, 10.18632/oncotarget.7876 Hutterer, 2014, Low preoperative lymphocyte-monocyte ratio (LMR) represents a potentially poor prognostic factor in nonmetastatic clear cell renal cell carcinoma, Urol Oncol, 32, 1041, 10.1016/j.urolonc.2014.04.001 Chang, 2016, Prognostic value of preoperative lymphocyte to monocyte ratio in patients with nonmetastatic clear cell renal cell carcinoma, Tumour Biol, 37, 4613, 10.1007/s13277-015-4300-7 Edge, 2010, The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM, Ann Surg Oncol, 17, 1471, 10.1245/s10434-010-0985-4 Fuhrman, 1982, Prognostic significance of morphologic parameters in renal cell carcinoma, Am J Surg Pathol, 6, 655, 10.1097/00000478-198210000-00007 Harrell, 1996, Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors, Stat Med, 15, 361, 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4 Vasudev, 2012, Renal cancer biomarkers: the promise of personalized care, BMC Med, 10, 112, 10.1186/1741-7015-10-112 Sun, 2011, Prognostic factors and predictive models in renal cell carcinoma: a contemporary review, Eur Urol, 60, 644, 10.1016/j.eururo.2011.06.041 Hoffmann, 2002, Spontaneous apoptosis of circulating T lymphocytes in patients with head and neck cancer and its clinical importance, Clin Cancer Res, 8, 2553 Feng, 2014, Lymphopenia predicts poor prognosis in patients with esophageal squamous cell carcinoma, Medicine (Baltimore), 93, e257, 10.1097/MD.0000000000000257 Kondo, 2004, High expression of chemokine gene as a favorable prognostic factor in renal cell carcinoma, J Urol, 171, 2171 Mantovani, 2008, Cancer-related inflammation, Nature, 454, 436, 10.1038/nature07205 Parkin, 2001, An overview of the immune system, Lancet, 357, 1777, 10.1016/S0140-6736(00)04904-7 Hutterer, 2013, Tumour-associated macrophages might represent a favourable prognostic indicator in patients with papillary renal cell carcinoma, Histopathology, 63, 309, 10.1111/his.12163 Condeelis, 2006, Macrophages: obligate partners for tumor cell migration, invasion, and metastasis, Cell, 124, 263, 10.1016/j.cell.2006.01.007 Pollard, 2004, Tumour-educated macrophages promote tumour progression and metastasis, Nat Rev Cancer, 4, 71, 10.1038/nrc1256 Evani, 2013, Monocytes mediate metastatic breast tumor cell adhesion to endothelium under flow, FASEB J, 27, 3017, 10.1096/fj.12-224824 Pollard, 2009, Trophic macrophages in development and disease, Nat Rev Immunol, 9, 259, 10.1038/nri2528 Lin, 2006, Macrophages regulate the angiogenic switch in a mouse model of breast cancer, Cancer Res, 66, 11238, 10.1158/0008-5472.CAN-06-1278 Jetten, 2014, Anti-inflammatory M2, but not pro-inflammatory M1 macrophages promote angiogenesis in vivo, Angiogenesis, 17, 109, 10.1007/s10456-013-9381-6